Literature DB >> 1527089

High levels of "complexed" interleukin-6 in human blood.

L T May1, H Viguet, J S Kenney, N Ida, A C Allison, P B Sehgal.   

Abstract

The biochemical nature of endogenous interleukin-6 (IL-6) as it exists in human serum or plasma was investigated. Serum from a patient following bone marrow (BM) transplantation and fresh plasma samples from patients with epidermolysis bullosa or psoriasis, as well as from normal volunteers, were fractionated through G-200 columns and each of the eluted fractions assayed for IL (interleukin)-6 content using enzyme-linked immunosorbent assays (ELISAs) based on the monoclonal antibody (mAb) pairs IG61/5IL6 or 4IL6/5IL6 and in the B9 hybridoma growth factor bioassay. The IG61/5IL6 ELISA and the B9 assay detected IL-6 in BM serum almost exclusively of molecular mass approximately 20 kDa. In contrast, the 4IL6/5IL6 ELISA detected strong IL-6 immunoreactivity in complexes of size 100-150 and 400-500 kDa. IL-6 present in the 100-150- and 400-500-kDa complexes was purified by immunoaffinity chromatography through a 5IL6 mAb column. The 5IL6 mAb immunoaffinity column eluate of the respective pools from BM serum contained IL-6 at concentrations approaching 1 microgram/ml as characterized by Western blotting. Sufficient IL-6 and associated proteins were purified by 5IL6 mAb immunoaffinity column chromatography of the 100-150-kDa complex from 0.8 ml of BM serum to allow (i) verification of three of the polypeptides as IL-6 by amino-terminal sequencing (estimate of IL-6 in original serum sample: 5-10 micrograms/ml), (ii) identification by amino acid sequencing of the "associated" proteins as complement factor C3b (carboxyl-terminal of the alpha-chain), complement factor C4b (gamma-chain), C-reactive protein, and albumin, and (iii) detection of an "associated" polypeptide consistent with the soluble IL-6 receptor. Taken together, these data establish that IL-6 is present at unexpectedly high concentrations in human blood in novel biochemical complexes that include other plasma proteins, which in turn, can camouflage IL-6 immunoreactivity and bioactivity as measured in conventional assays.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.

Authors:  Shalini Chaturvedi; Derick Siegel; Carrie L Wagner; Jaehong Park; Helgi van de Velde; Jessica Vermeulen; Man-Cheong Fung; Manjula Reddy; Brett Hall; Kate Sasser
Journal:  Br J Clin Pharmacol       Date:  2015-06-04       Impact factor: 4.335

Review 2.  A review on nanomaterial-based field effect transistor technology for biomarker detection.

Authors:  Leila Syedmoradi; Anita Ahmadi; Michael L Norton; Kobra Omidfar
Journal:  Mikrochim Acta       Date:  2019-11-01       Impact factor: 5.833

3.  Complement profiles in human skin lymph during the course of irritant contact dermatitis.

Authors:  C U Brand; P J Späth; T Hunziker; A Limat; L R Braathen
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  Cytokine regulation of low-affinity IgE receptor (CD23) on monocytes from asthmatic subjects.

Authors:  A Vecchiarelli; A Siracusa; C Monari; D Pietrella; C Retini; C Severini
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 5.  Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function.

Authors:  J Fukata; H Imura; K Nakao
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

6.  Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines.

Authors:  A M Bleau; M C Levitchi; H Maurice; P du Souich
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Population differences in proinflammatory biology: Japanese have healthier profiles than Americans.

Authors:  Christopher L Coe; Gayle D Love; Mayumi Karasawa; Norito Kawakami; Shinobu Kitayama; Hazel R Markus; Russell P Tracy; Carol D Ryff
Journal:  Brain Behav Immun       Date:  2010-11-26       Impact factor: 7.217

8.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.

Authors:  F De Benedetti; M Massa; P Pignatti; S Albani; D Novick; A Martini
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  The acute phase protein response in patients receiving subcutaneous IL-6.

Authors:  R E Banks; M A Forbes; M Storr; J Higginson; D Thompson; J Raynes; J M Illingworth; T J Perren; P J Selby; J T Whicher
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.

Authors:  G Strassmann; M Fong; C E Freter; S Windsor; F D'Alessandro; R P Nordan
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.